Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 Study of the Safety of AAV2/8-LSPhGAA (ACTUS-101) in Late-onset Pompe Disease

Trial Profile

A Phase 1 Study of the Safety of AAV2/8-LSPhGAA (ACTUS-101) in Late-onset Pompe Disease

Status: Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 03 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ACTUS 101 (Primary)
  • Indications Glycogen storage disease type II
  • Focus Adverse reactions
  • Sponsors Actus Therapeutics; Asklepios BioPharmaceutical
  • Most Recent Events

    • 27 Jun 2023 Planned End Date changed from 1 Apr 2028 to 1 Mar 2026.
    • 27 Jun 2023 Status changed from recruiting to active, no longer recruiting.
    • 25 May 2022 According to ClinicalTrials.gov record, protocol has been amended to increase patient number from 8 to 13, treatment arm changed from 3 to 5. Primary endpoint changed from 52 weeks to 78 weeks, other endpoint also changed. Official title also changed
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top